Overdosing on chemo: A common gene test could save hundreds of lives each year
A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.
Source: mendocinobeacon.com
Stay updated with breaking news from Mark Fleury. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.
A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.
A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.
A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.
A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.